PD-0001CETUXIMAB EVERY 2 WEEKS WITH FIRST-LINE CHEMOTHERAPY IN APEC STUDY PATIENTS WITH METASTATIC COLORECTAL CANCER GROUPED ACCORDING TO EGFR EXPRESSION
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI